DIHYDROFOLATE REDUCTASE INHIBITION BY EPIGALLOCATECHIN GALLATE COMPOUNDS
This invention relates to the identification, production and use of Dihydrofolate Reductase (DHFR) inhibitors based on the green tea catechin Epigallocatechin Gallate (EGCG). These inhibitors are, for example, useful in therapy, in particular for the treatment of cancer, infection and inflammatory c...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention relates to the identification, production and use of Dihydrofolate Reductase (DHFR) inhibitors based on the green tea catechin Epigallocatechin Gallate (EGCG). These inhibitors are, for example, useful in therapy, in particular for the treatment of cancer, infection and inflammatory conditions.
L'invention concerne l'identification, la production et l'utilisation des inhibiteurs de la dihydrofolate réductase (DHFR) sur la base de la catéchine épigallocatéchine gallate (EGCG) du thé vert. Ces inhibiteurs sont utiles, par exemple, en thérapie, notamment pour le traitement du cancer, d'états infectieux et inflammatoires. |
---|